Transcatheter treatment of hepatocellular carcinoma with Doxorubicin-loaded DC Bead (DEBDOX): technical recommendations
about
New advances in hepatocellular carcinomaTransarterial chemoembolization: Evidences from the literature and applications in hepatocellular carcinoma patientsExtravascular use of drug-eluting beads: a promising approach in compartment-based tumor therapyTranscatheter embolization therapy in liver cancer: an update of clinical evidencesClinical trials of combined molecular targeted therapy and locoregional therapy in hepatocellular carcinoma: past, present, and futureHow I do it: Cone-beam CT during transarterial chemoembolization for liver cancerEngineering Biomaterial-Drug Conjugates for Local and Sustained Chemotherapeutic DeliveryComparison of drug release and pharmacokinetics after transarterial chemoembolization using diverse lipiodol emulsions and drug-eluting beadsImaging of hepatocellular carcinoma: diagnosis, staging and treatment monitoringUltrafast cone-beam computed tomography imaging and postprocessing data during image-guided therapeutic practice.Safety of chemotherapeutic infusion or chemoembolization for hepatocellular carcinoma supplied exclusively by the cystic artery.Imaging Biomarkers of Tumor Response in Neuroendocrine Liver Metastases Treated with Transarterial Chemoembolization: Can Enhancing Tumor Burden of the Whole Liver Help Predict Patient Survival?Transarterial chemoembolization using 40 µm drug eluting beads for hepatocellular carcinomaTransarterial embolization therapies for the treatment of hepatocellular carcinoma: CEPO review and clinical recommendationsTransarterial chemoembolization using gelatin sponges or microspheres plus lipiodol-doxorubicin versus doxorubicin-loaded beads for the treatment of hepatocellular carcinomaVolumetric assessment of tumour response using functional MR imaging in patients with hepatocellular carcinoma treated with a combination of doxorubicin-eluting beads and sorafenib.Functional magnetic resonance imaging response of targeted tumor burden and its impact on survival in patients with hepatocellular carcinoma.Randomized comparison of selective internal radiotherapy (SIRT) versus drug-eluting bead transarterial chemoembolization (DEB-TACE) for the treatment of hepatocellular carcinoma.Ultrafast cone-beam computed tomography: a comparative study of imaging protocols during image-guided therapy procedure.Pattern of retained contrast on immediate postprocedure computed tomography (CT) after particle embolization of liver tumors predicts subsequent treatment response.Systematic review comparing the safety and efficacy of conventional and drug-eluting bead transarterial chemoembolization for inoperable hepatocellular carcinoma.Conventional transarterial chemoembolization versus drug-eluting bead transarterial chemoembolization for the treatment of hepatocellular carcinoma.Transarterial hepatic chemoembolization with 70-150 µm drug-eluting beads: assessment of clinical safety and liver toxicity profileEvaluation of the delivered activity of yttrium-90 resin microspheres using sterile water and 5 % glucose during administration.DC BeadM1™: towards an optimal transcatheter hepatic tumour therapy.Doxorubicin induces apoptosis by targeting Madcam1 and AKT and inhibiting protein translation initiation in hepatocellular carcinoma cells.Novel imaging biomarkers of response to transcatheter arterial chemoembolization in hepatocellular carcinoma patients.Phase II study of chemoembolization with drug-eluting beads in patients with hepatic neuroendocrine metastases: high incidence of biliary injury.Transcatheter intra-arterial infusion of doxorubicin loaded porous magnetic nano-clusters with iodinated oil for the treatment of liver cancerPotentiality and boundaries of use of sorafenib in patients with hepatocellular carcinoma: awaiting the results of ongoing clinical trials.Perspectives on the design of clinical trials combining transarterial chemoembolization and molecular targeted therapy.Chemoembolization and radioembolization for hepatocellular carcinoma.Chemoembolization in patients with hepatocellular carcinoma.Repeated intra-arterial therapy via the cystic artery for hepatocellular carcinoma.Therapeutic magnetic microcarriers guided by magnetic resonance navigation for enhanced liver chemoembilization: a design review.Treatment of intermediate-stage hepatocellular carcinoma.Transarterial chemoembolization for hepatocellular carcinoma: A review of techniques.Cone Beam Computed Tomography (CBCT) in the Field of Interventional Oncology of the Liver.Treatment of Liver Cancer.Locoregional and systemic therapy for hepatocellular carcinoma.
P2860
Q26749329-048499C5-C248-4649-AB48-FD8B40A6B5BBQ26799469-C8E6B9F4-EA33-4AC5-AB4C-EB8CB8BA7ACFQ27000814-A78E653B-B5D2-4432-AE02-EE17656D9942Q27003849-3D05865C-C6EA-470D-996B-F8B08B202486Q27013055-BE9F46DD-350E-4D83-B19F-5EBF7F26AC89Q28087066-7A827560-000B-4EBD-A593-E10D42696D3DQ28087367-7FC70386-4502-48E0-8D5D-ECED794E5504Q28542950-077D8749-34FB-4614-AB0A-0B19DE255F87Q30436747-3D0C232E-E6CF-4F4E-A8C3-E0EFB4E1FCCFQ30841508-19075F5B-1584-4444-AFA2-25A9D1EF24F4Q33162177-0BAB5127-9AAF-4A46-97FF-9E4C7ED70C4CQ33658301-1CD391E0-6F41-49EE-BB70-F24FB3E97059Q33718635-EFCC5A32-47E2-4EFA-8471-167908FAEC0BQ34702094-9C6128B4-9D8E-45EA-99B1-DFABF3ABD936Q34975108-75D2B530-484B-488C-8B1E-09CD6CBC24B2Q35073497-B3B2DF90-ADA7-46AD-A311-8F2BB8B2DF33Q35163735-CEF0927C-8152-4C53-AB95-1B6D529FA74FQ35164855-246CA087-BAE0-45B6-B1CA-BE90B71142E8Q35271193-8EA0500A-2181-4AFF-B7EF-F4D66CAE098BQ35383390-76E94146-69F4-4248-9C22-BA39CC196A0BQ35411599-722EB871-69B5-48DE-99A2-899110F1CF93Q35658940-9E109A93-FE37-4AB3-BC57-04B1BA478192Q35795014-C9EFBA43-294A-4907-B1F2-C8F3545B277BQ36157591-63185219-62EE-4383-BD42-08E300120AA0Q36378569-5F36CEDE-AAFA-41CE-A585-11D4447EC55BQ36414381-9C2E55F2-93AB-426C-972E-0B93124ED756Q36419100-2C611ADF-835C-4239-811D-78B06098F6C7Q36681218-C2ED25E4-3449-40AA-A55C-B74BCA76B7ABQ36689688-224D7356-2404-4F1D-B55D-1B1502EDBA7EQ37017008-EE1DF464-9540-4DE8-8997-F27822BAF79EQ37140678-526498DC-B962-4ABC-95CD-FB3B7BB1AF0DQ37238192-4E2E299D-47F8-4F33-BA71-276E3A8CFDA9Q38155505-11938709-D476-46A2-BF47-BE88060E178DQ38165802-9F90FD26-6553-45E4-9BA5-88E9C163D812Q38179297-3430E614-BB26-482F-ADC4-683E241F0CE2Q38236876-F06C5FB2-A503-435D-9099-1E874D2B221BQ38302096-E9E820DE-95FD-4567-B600-DAC488806704Q38547878-C809CC20-A694-4466-AF94-342120FDC1F3Q38549768-5C7806D1-FC6E-482E-85B6-88E3EA371B08Q38686790-B82E9DAF-3D41-4C16-A968-8FAA62EBD473
P2860
Transcatheter treatment of hepatocellular carcinoma with Doxorubicin-loaded DC Bead (DEBDOX): technical recommendations
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Transcatheter treatment of hep ...... OX): technical recommendations
@en
Transcatheter treatment of hepatocellular carcinoma with Doxorubicin-loaded DC Bead
@nl
type
label
Transcatheter treatment of hep ...... OX): technical recommendations
@en
Transcatheter treatment of hepatocellular carcinoma with Doxorubicin-loaded DC Bead
@nl
prefLabel
Transcatheter treatment of hep ...... OX): technical recommendations
@en
Transcatheter treatment of hepatocellular carcinoma with Doxorubicin-loaded DC Bead
@nl
P2093
P2860
P921
P1476
Transcatheter treatment of hep ...... OX): technical recommendations
@en
P2093
Anthony Watkinson
Elizabeth O'Grady
James G Caridi
Jean-Francois H Geschwind
Johannes Lammer
Katerina Malagari
Maria Isabel Real
Marta Burrel
Riccardo Lencioni
Robert C G Martin
P2860
P2888
P304
P356
10.1007/S00270-011-0287-7
P577
2011-10-19T00:00:00Z
2012-10-01T00:00:00Z